Perspective Therapeutics Inc (NYSEAMERICAN: CATX) stock closed at $11.74 on 7/10/24 after a major increase of 10.7%. Moreover, above average trading volume at 131% of normal accompanied the advance. The stock has risen 4.8% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
CATX’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to be Value Creation neutral.
Perspective Therapeutics has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Perspective Therapeutics has a very low Appreciation Score of 1 but a very high Power Rating of 98, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment